PATENT CLAIM ANALYSIS

Application Number: 15965340
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["424", "474000"]

Abstract:
A hard shell capsule includes a body and a cap cooperatively defining a hollow core hard shell capsule. Each of the body and the cap has a composition that includes a polymer forming a hard polymer structure of the body and of the cap, at least one of the body and the cap composition including a therapeutically effective amount of a drug(s) used in the treatment of irritable bowel syndrome loaded throughout the body and/or cap. The second drug(s) may be filled in the capsule core.

Claim (Index 19):
The hard shell capsule of  claim 18  wherein the said drug(s) is selected from the group of linaclotide, lubiprostone, and alosetron, and the additional drug(s) is selected from the group rifaximin, eluxadoline, anti-depressants, anti-anxiety agents and probiotics.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 91.0
- Lexical Diversity: 1.95918
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15859342', '12841008', '13508409', '15595848', '15308767']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7407199928810243
- 35 USC 102 Novelty (BERT): 0.524832106779313
- Combined Prediction Score: 0.7191312042708532
- Mean Citation Score: 241.557508
- Max Citation Score: 327.0619
- Similarity Product: 225.98339260640145

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test